This month Retrovirology publishes the meeting abstracts from the 10 th annual Institute of Human
Is there value to publishing Meeting Abstracts? On several levels, the answer appears to be "yes". While the IHV abstracts are the first of its kind for Retrovirology, our experience with publishing meeting reports [2] [3] [4] [5] [5] , attended by ~125 scientists, was accessed 610 times in the first ten days after its publication. Independently, Scherer et al. [6] found in a study of 2,391 meeting abstracts that 51% of the abstracts later appeared as full articles in journals. In another survey, 84% of journals were found to permit the citation of meeting abstracts in bibliographies [7] . Because on average an entire year lags between the time that a paper/ poster is presented at a meeting and its eventual publication in a journal, publishing meeting abstracts arguably serves to narrow a knowledge gap between those who attended a meeting and those who did not [7] . Moreover, extant data support that the "open access" approach to publishing scientific information promotes a higher rate of citation to the published work [8] . Thus, it stands to reason that there is value for both authors and readers of Retrovirology meeting abstracts.
Let me close this writing by telling you a personal anecdote which illustrated for me why archiving of meeting abstracts is important. In the early 1980's, I was a graduate student working in one of three laboratories worldwide which were competing on the cloning and the characterization of the cytomegalovirus (CMV) immediate-early (IE) promoter. This is the same CMV promoter that is res-ident in the many mammalian expression vectors which most of you purchase commercially. My memory tells me (although my memory has faded with age) that between 1981 to 1984, I made several presentations on CMV promoter research at the then annual Herpesvirus meeting held at Cold Spring Harbor. Later, in 1990, a patent for the use of the CMV IE promoter was filed by a competitor's group. Many years passed, until approximately five years ago when I unexpectedly received a telephone call from a patent attorney at a high-priced law firm in New York City. The attorney represented a biotech firm which was keen on contesting the issued CMV IE patent. The attorney wanted to know "What did I say publicly about my CMV IE promoter research at meetings?" "And when did I say them?". I recall at that moment when confronted to recall accurately minute historical details critical to a legal contest, I wished fervently for the existence of an open access, easily searchable, repository of meeting abstracts.
Retrovirology is committed to the goal of free public access to permanently archived digitally formatted scientific information. Meeting abstracts published in Retrovirology are initially viewable online in our journal, and are then permanently deposited into the PubMed Central archive. Retrovirology is currently accessed ~1,000 times daily. If you are a meeting organizer interested in the rapid and broad dissemination (with permanent archiving) of the presentations from your conference, it may be worth your while to consider publishing your meeting in Retrovirology.
